TOTAL DE VISITAS

Seguidores

miércoles, 1 de abril de 2020

REUMATOLOGÍA - Burmester et al - Efficacy and safety of subcutaneous tocilizumab vs intravwenous tocilizumab in combination with traditional DMARDs in pacientes with RA al week 97 (SUMACTA)

No hay comentarios:

Publicar un comentario